 |
|
Short-term Prognosis After Emergency Department Diagnosis of TIA
S. Claiborne Johnston, MD, MPH;
Daryl R. Gress, MD;
Warren S. Browner, MD, MPH;
Stephen Sidney, MD, MPH
JAMA. 2000;284:2901-2906.
ABSTRACT
| |
Context Management of patients with acute transient ischemic attack (TIA) varies widely, with some institutions admitting all patients and others proceeding with outpatient evaluations. Defining the short-term prognosis and risk factors for stroke after TIA may provide guidance in determining which patients need rapid evaluation.
Objective To determine the short-term risk of stroke and other adverse events after emergency department (ED) diagnosis of TIA.
Design and Setting Cohort study conducted from March 1997 through February 1998 in 16 hospitals in a health maintenance organization in northern California.
Patients A total of 1707 patients (mean age, 72 years) identified by ED physicians as having presented with TIA.
Main Outcome Measures Risk of stroke during the 90 days after index TIA; other events, including death, recurrent TIA, and hospitalization for cardiovascular events.
Results During the 90 days after index TIA, 180 patients (10.5%) returned to the ED with a stroke, 91 of which occurred in the first 2 days. Five factors were independently associated with stroke: age greater than 60 years (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.1-2.7; P = .01), diabetes mellitus (OR, 2.0; 95% CI, 1.4-2.9; P<.001), symptom duration longer than 10 minutes (OR, 2.3; 95% CI, 1.3-4.2; P = .005), weakness (OR, 1.9; 95% CI, 1.4-2.6; P<.001), and speech impairment (OR, 1.5; 95% CI, 1.1-2.1; P = .01). Stroke or other adverse events occurred in 428 patients (25.1%) in the 90 days after the TIA and included 44 hospitalizations for cardiovascular events (2.6%), 45 deaths (2.6%), and 216 recurrent TIAs (12.7%).
Conclusions Our results indicate that the short-term risk of stroke and other adverse events among patients who present to an ED with a TIA is substantial. Characteristics of the patient and the TIA may be useful for identifying patients who may benefit from expeditious evaluation and treatment.
INTRODUCTION
Transient ischemic attacks (TIAs) are common1: approximately 300,000 TIAs occur each year in the United States based on recent estimates of stroke incidence.2-3 A recent survey suggested a much higher incidence, with 1 in 15 of those older than age 65 years reporting a history of TIA.4 About 15% of patients experiencing stroke report a history of TIA.5 Effective prevention of subsequent stroke in patients with TIAs could significantly reduce the overall stroke incidence.6
Evaluation and treatment of patients with stroke is generally rapid, in part because management of ongoing cerebral ischemia may reduce the final injury and because patients often have a disability that requires care.7 The need for urgent intervention is less clear for patients with TIA, who have usually returned to their baseline level of function by the time they are evaluated. While some interventions are known to be effective after TIA, such as antiplatelet agents, anticoagulation for atrial fibrillation, and endarterectomy for symptomatic carotid artery stenosis,8 it is not known whether more urgent therapy is justified. Hospitalization or rapid evaluation may be warranted only in patients with high short-term risk because urgent secondary prevention strategies are costly.9-12
Several studies have evaluated stroke risk after TIA,13-24 but they have generally been small, have failed to examine the short-term risk separately, and have not identified which factors are associated with an increased risk of stroke. The most reliable data on short-term prognosis after TIA come from 2 population-based studies,25-26 but their results have limited applicability to current clinical management because the studies were performed many years ago and included fewer than 200 cases each; 1 study did not include the risk of stroke in the first few days after the TIA.
It is often impossible to confirm a diagnosis of TIA since symptoms are transient and may have nonischemic etiologies such as seizure, syncope, and migraine. In fact, agreement between independent observers on TIA diagnosis is poor, even among neurologists.27-28 Clinical decisions are based on the final diagnosis of the treating physician, who is often an emergency-department (ED) physician, internist, or family practitioner.29 Since those patients given a diagnosis of TIA by the treating physician form the cohort currently recognized in practice, it is essential to study these patients regardless of whether the diagnosis is confirmed by a neurologist.
Lack of knowledge about the acute natural history of patients with TIA has led to variability in clinical practice.30 Guidelines are generally vague about evaluation and treatment.8-9 To determine the short-term risk of stroke and other adverse events after TIA and to identify risk factors, we performed a cohort study of patients diagnosed as having TIA in the EDs of hospitals belonging to a large health maintenance organization. We used the treating physicians' diagnoses of TIA to define the cohort so that results would be generalizable to institutions where neurologists do not routinely evaluate patients with TIA in the ED.
METHODS
Patients
Kaiser-Permanente Northern California is a health maintenance organization with 16 hospitals in the San Francisco Bay Area, Sacramento, and Santa Rosa, Calif. There are 2.9 million enrollees, with demographics similar to the regional population.31 Beginning in March 1997, ED physicians at all 16 facilities were asked to select a primary diagnosis (including TIA) for all patient visits. These diagnoses were entered into a database.
Patients (n = 1797) seen in the ED and diagnosed as having TIA from March 1997 through February 1998 were identified. Those who did not have ED records available (n = 30), were not members of the health plan (n = 27), had coded diagnoses other than TIA (n = 25), or had a prior TIA treated in the ED during the study period (n = 8) were excluded. Medical records were reviewed by trained analysts in conjunction with a neurologist. A neurologist blinded to follow-up events reviewed the medical records of all patients in whom the diagnosis of TIA was unclear based on physician documentation or analyst review. Definite TIA was defined based on World Health Organization criteria32 as rapidly developed clinical signs of focal or global disturbance of cerebral function lasting fewer than 24 hours, with no apparent nonvascular cause. Analyses of definite TIA cases are reported separately from the primary analysis, which is based on the ED diagnosis.
Patient characteristics, medical history, TIA symptom details, medications, examination findings attributed to the TIA, and treatment plans were abstracted using predefined criteria. Emergency department physician notes were considered the primary source, supplemented with nursing notes when necessary. Subtypes of speech impairment and vision loss were not identified, given the difficulty of distinguishing dysarthria from aphasia and monocular blindness from a homonymous visual field deficit based on patient recollection. Heart rate and blood pressure were recorded from the initial ED measurement. A murmur was coded as absent if not mentioned in notation of cardiac auscultation. A bruit was coded as absent only if specifically noted in the record.
Outcomes
Patients were followed up for 90 days after presentation. Strokes, TIAs, deaths, and hospitalizations for cardiovascular events were identified from computerized databases and review of medical records. Hospitalizations outside the system were recorded in a separate database, so it was possible to obtain very complete follow-up information.33-34
The primary outcome was stroke occurring within 90 days of TIA presentation. Stroke was defined as a rapidly developed focal or global disturbance of cerebral function, with no apparent nonvascular cause, lasting more than 24 hours or until death,32 and distinguishable from the event leading to the initial TIA diagnosis. A final stroke diagnosis required independent confirmation by 2 neurologists, who also determined whether the stroke led to hospitalization or was disabling (defined as a Modified Rankin Score of  2).35 There were initial disagreements in 2% of stroke diagnoses, 4% of hospitalization determinations, and 12% of disability assessments; all disagreements were resolved through discussion.
Diagnosis of recurrent TIA required confirmation by a reviewing neurologist and a written diagnosis in the medical record. Cardiovascular events requiring hospitalization included myocardial infarction, unstable angina, congestive heart failure, and ventricular arrhythmias. Deaths were identified from medical records, enrollment files, and the Social Security Death Index.
Statistical Analysis
The risks of stroke, recurrent TIA, and cardiovascular events were determined as the percentage of patients with these events during the 90-day period after resolution of all TIA symptoms. For patients without documentation of symptom resolution, follow-up began at the time of ED discharge.
In univariate analysis, we identified clinical signs and symptoms that were significant risk factors for stroke using the Fisher exact test. Variables that were associated with stroke risk (at P<.20) were included in multivariable logistic regression models, and those no longer associated with risk (at P>.10) were removed in a stepwise fashion. To simplify the models, continuous variables were dichotomized at prespecified cutpoints (eg, diastolic blood pressure = 90 mm Hg, systolic blood pressure = 140 mm Hg). Because specific neurologic signs and symptoms were often correlated, neurologic abnormalities present either by history or on examination were combined (eg, weakness by history or on examination). Variables representing treatments initiated after ED evaluation were not included in the model since they were likely to be associated with perceived prognosis and could alter prognosis; these complex interactions would limit their interpretation. First-order interaction terms with combinations of all independent predictors were reintroduced into the multivariable model 1 at a time.
Kaplan-Meier life-table analysis was used to illustrate the timing of follow-up events. Since a stroke occurring after TIA but before evaluation would not have been included, resulting in an underestimation of stroke risk, we excluded person-time prior to evaluation in those patients whose symptoms resolved prior to ED arrival. Follow-up was terminated at death or endarterectomy. The protocol was approved by the institutional review board of Kaiser-Permanente Northern California. The risk of study participation was considered minimal, so informed consent was not required.
RESULTS
Of the 1707 patients with a diagnosis of TIA, more than 99% (n = 1697) arrived within 1 day of symptom onset. Mean age was 72 years and mean symptom duration was 207 minutes. The mean heart rate and blood pressure were 78/min and 161/83 mm Hg, respectively. Risk factors for vascular disease were common, and included diabetes mellitus, hypertension, and known history of vascular disease (Table 1). Symptoms were present on arrival in half of the patients (n = 854).
|
|
|
|
Table 1. Characteristics of Patients With TIA and Associated 90-Day Stroke Risk (N = 1707)*
|
|
|
Strokes occurred in 180 patients (10.5%) within 90 days of TIA presentation, 91 of which occurred during the first 2 days (Figure 1A). Strokes were fatal in 38 patients (21%), and disabling in another 115 (64%). Seventy-six percent of patients required hospitalization. Only 7% of strokes were not disabling and did not require hospitalization.
|
|
|
|
Figure. Kaplan-Meier Life-Table Analysis of Survival Free From Stroke and All Adverse Events
Observations were indexed to the time of TIA symptom resolution. Time between symptom resolution and evaluation in the emergency department did not contribute to the analysis since a stroke occurring during this period would have excluded a case. Therefore, some patients entered the analysis after time zero. A, Adverse events include stroke, recurrent transient ischemic attack (TIA), hospitalization for a cardiovascular event, and death. B, Risk factors included age >60 years, duration of symptoms >10 minutes, diabetes mellitus, weakness associated with the transient ischemic attack (TIA), and speech impairment associated with the TIA. Follow-up was censored at the time of death or endarterectomy, so numbers do not reflect the total number of TIA patients at risk during the entire period.
|
|
|
Stroke Risk Factors
Age older than 60 years, diabetes mellitus, duration of the TIA, symptoms on arrival, and signs or symptoms of weakness, speech impairment, and gait disturbance were associated with increased risk of stroke in univariate analysis, while symptoms of numbness were associated with reduced risk (Table 1). Medications taken prior to evaluation did not influence prognosis.
A variety of treatments were initiated in the ED or at discharge (Table 2). Patients prescribed anticoagulation at discharge from the ED were more likely to have a stroke, but a perception of greater stroke risk may have prompted more aggressive therapy in these patients. When analysis was limited to the 918 patients who were not previously taking an anticoagulant or antiplatelet agent, those initiating an antiplatelet agent (n = 775) tended to have lower stroke risk than those receiving no prophylactic medication (n = 143) (9% vs 13%; P = .12). The same trend was apparent in evaluating any prophylactic therapy vs none (9% vs 13%; P = .17). In multivariable models adjusting for prognostic factors, neither of these variables was significant (new antiplatelet therapy vs none: odds ratio [OR], 0.63, 95% confidence interval [CI], 0.37-1.05, P = .10; any new prophylactic therapy vs none: OR, 0.66, 95% CI, 0.38-1.15, P = .14).
|
|
|
|
Table 2. Treatment of Patients With TIA and Associated 90-Day Stroke Risk (N = 1707)*
|
|
|
Five factors were independently associated with 90-day stroke risk (Table 3). A simple index (1 point for each risk factor) was useful in estimating risk, which varied from 0% in patients with no factors to 34% in those with all 5 (Figure 1B), though observations were sparse at the extremes (Table 4).
|
|
|
|
Table 3. Independent Risk Factors for Stroke Within 90 Days (N = 1707)*
|
|
|
|
|
|
|
Table 4. 90-Day Stroke Risk by Number of Risk Factors*
|
|
|
Models Including First-Order Interactions
The only significant interaction term was one that represented speech impairment in patients with symptoms lasting more than 10 minutes (OR, 6.0; 95% CI, 1.9-6.5; P = .003). Symptom duration was no longer a significant predictor of stroke in that model, and speech impairment alone was associated with a lower risk of stroke (OR, 0.29; 95% CI, 0.09-0.95; P = .04). The magnitude of other predictors was unchanged in the model with the interaction term.
Other Adverse Outcomes
Hospitalization for cardiovascular events occurred in 44 patients (2.6%) within 90 days of the TIA. Reasons for admission included congestive heart failure (n = 22), myocardial infarction (n = 13), ventricular arrhythmia (n = 5), and unstable angina (n = 4). Forty-five patients (2.6%) died within 90 days of the TIA; causes of death were strokes (n = 20), cardiovascular events (n = 9), infections (n = 4), cancer (n = 4), pancreatitis (n = 1), and unknown (n = 7). Recurrent TIA occurred in 216 patients (12.7%), and was associated with hospitalization in 106 patients (6.2%). An adverse event, including stroke, cardiovascular hospitalization, death, or recurrent TIA, occurred in 428 patients (25.1%) in the 90 days after the TIA. More than 50% of adverse events occurred within the first 4 days.
Validation of the ED Diagnosis
The TIA diagnosis was thought improbable by a reviewing neurologist in 96 patients (5.6%), in whom symptoms were attributed to syncope (n = 24), peripheral vestibulopathy (n = 12), anxiety (n = 11), migraine (n = 10), seizure (n = 6), medication effects (n = 6), neuropathy (n = 4), transient global amnesia (n = 4), and other etiologies (n = 19). Three of these patients had a stroke during 90-day follow-up. In an additional 182 patients (10.6%), neurologic symptoms improved but complete resolution within 24 hours was not documented; 19 of these patients (10.4%) had a stroke during follow-up. The stroke risk was not significantly different in the full cohort of patients with TIA and in the subgroup with TIAs confirmed by neurologist review (10.5% vs 11.1%; P = .64 by the Fisher exact test). Compared with the full cohort, independent risk factors for stroke were similar in those with TIA diagnoses after neurologist review (age >60 years: OR, 1.8, 95% CI, 1.1-2.8; diabetes: OR, 2.4, 95% CI, 1.6-3.4; duration >10 min: OR, 2.5, 95% CI, 1.3-4.6; weakness: OR, 2.2, 95% CI, 1.6-3.2; speech impairment: OR, 1.3, 95% CI, 1.0-1.9).
COMMENT
Transient ischemic attacks are ominous, carrying a substantial short-term risk of stroke, hospitalization for cardiovascular events, and death. The 90-day stroke risk was 10.5%, over 50 times that expected in a cohort of similar age.2, 36 Half of the strokes occurred within 2 days of the TIA. Short-term risks of cardiovascular events, death, and recurrent TIA were also high, with a combined 25.1% risk of an adverse event during the 3 months after a TIA.
Diagnosis of TIA is often problematic. It may be difficult to determine whether focal neurologic symptoms are due to ischemia from impaired cerebral circulation or due to seizure, migraine, or even syncope. Prior studies have required a neurologist's evaluation and strict entry criteria to establish the diagnosis of TIA,25-26 but this does not solve the problem. Even among neurologists there is low interobserver agreement in the diagnosis of TIA.27-28 Furthermore, evaluation by a neurologist is often not part of routine practice, in which ED and primary care physicians are primarily responsible for TIA diagnosis and management. In these settings, the diagnosis of TIA made by physicians caring for a patient is more useful for assessing natural history and defining stroke risk factors.29 Therefore, we focused on the ED diagnosis of TIA. Based on neurologist review, these diagnoses appeared to be accurate in 94% of patients, although complete resolution of symptoms was not documented in an additional 11%. The prognosis of patients whose diagnoses were confirmed by neurologist review was not different from that of the entire cohort, suggesting that the ED diagnosis of TIA is reasonably reliable.
The short-term risk that we observed was similar to that found in 2 smaller population-based studies of patients with TIA. Among 198 patients treated from 1955 to 1969 in Minnesota, the 3-month stroke risk was 10%,25 similar to what we observed. Another study reported a 4% stroke risk in the first month among 184 patients enrolled a median of 3 days after the index TIA26; failure to include strokes that occurred during the first 3 days may account for the lower stroke risk in that study.
We studied patients who were evaluated in EDs of the hospitals of a health maintenance organization. It is possible that disincentives to using the ED led to selection of cases perceived to be at greater risk. Patients had longer duration of symptoms than previously reported for a sample that included patients identified in outpatient clinics.37 The timing of presentation may also be important. Since more than half of strokes occurred within 2 days of the TIA, a patient arriving for evaluation 3 days after a TIA has already passed through the period of highest risk. Further study of patients diagnosed as having TIA in outpatient clinics is required to extend our findings to that group.
Currently available interventions for patients with TIA, including hospitalization and urgent carotid artery ultrasound, are expensive10-12 and may not be cost-effective if used in all such patients. Stratification of stroke risk allows targeting expensive interventions to those at greatest short-term risk. We found 5 independent risk factors for stroke within 90 days after TIA: age older than 60 years, diabetes mellitus, duration of episode greater than 10 minutes, and weakness and speech impairment with the episode. These risk factors may identify patients whose symptoms are more likely due to cerebral ischemia or may indicate pathophysiologic conditions associated with greater risk. Combining these risk factors, we identified subgroups with minimal (0%) and very high (34%) short-term risk of stroke.
Prospective validation with an independent cohort will be required before these risk factors can be combined into a prediction model.38 Validation also will be needed to test the possibility that the effects of symptom duration and speech impairment may be interdependent, as we observed in analyses that included interaction terms. Those analyses suggested that speech impairment may be a predictor only in those with symptoms lasting more than 10 minutes, or that symptom duration may be relevant only in those with speech impairment.
This observational study cannot provide reliable data on efficacy of therapies for TIA. It is likely that those perceived to be at highest risk of stroke were more often treated aggressively, and this would bias assessment of treatment benefit. Also, patients presented with TIAs despite any prophylactic antiplatelet or anticoagulant medications they were taking, so it is not surprising that prior medications did not reduce subsequent vascular events. Among patients who had not previously received an anticoagulant or antiplatelet medication, there was a nonsignificant trend toward reduced stroke risk in those who then received a prophylactic agent, but the size of the untreated group was small (n = 143).
The short-term risk of stroke and other adverse vascular events is high among patients who present to the ED with a TIA. Urgent intervention in this group may be warranted, and the efficacy of such intervention should be studied. Stratification of short-term stroke risk appears practical, and may allow more cost-effective intervention and more efficient study of prevention strategies.
AUTHOR INFORMATION
Author Contributions: Dr Johnston participated in the study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, provided statistical expertise, obtained funding, provided administrative, technical, or material support, and supervised conduct of the study.
Dr Gress participated in the study concept and design, critical revision of the manuscript for important intellectual content, and supervised conduct of the study.
Dr Browner participated in study concept and design, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, and provided statistical expertise.
Dr Sidney participated in the study concept and design, acquisition of data, analysis and interpretation of data, critical revision of the manuscript for important intellectual content, provided administrative, technical, or material support, and supervised conduct of the study.
Funding/Support: This work was funded by a grant-in-aid from the American Heart Association, Western State Affiliate. Dr Johnston is supported by the National Institutes of Health (NS 02042) and by a clinical research fellowship from the National Stroke Association. Dr Browner is supported by the National Institutes of Health (NS 36016).
Acknowledgment: We are grateful for the careful analysis of Carolyn Salazar, BA, Barbara Rowe, RN, and Michael Sorel, MPH.
Corresponding Author and Reprints: S. Claiborne Johnston, MD, MPH, Department of Neurology, Box 0114, University of California, San Francisco, 505 Parnassus Ave, M-798, San Francisco, CA 94143-0114 (e-mail: clayj{at}itsa.ucsf.edu).
Author Affiliations: Neurovascular Service, Department of Neurology, University of California, San Francisco (Drs Johnston and Gress); General Internal Medicine Section, San Francisco VA Medical Center, and Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco (Dr Browner); and the Division of Research, Kaiser-Permanente Northern California, Oakland (Drs Johnston and Sidney).
REFERENCES
| |
1. Brown RD Jr, Petty GW, O'Fallon WM, et al. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke. 1998;29:2109-2113.
FREE FULL TEXT
2. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 1998;29:415-421.
FREE FULL TEXT
3. Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999;30:2523-2528.
FREE FULL TEXT
4. National Stroke Association. TIA/ mini strokes: public knowledge and experience–Roper Starch worldwide survey. Roper Starch Worldwide; 2000.
5. Brainin M, McShane LM, Steiner M, et al. Silent brain infarcts and transient ischemic attacks. Stroke. 1995;26:1348-1352.
FREE FULL TEXT
6. Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. Stroke. 1999;30:1991-1994.
FREE FULL TEXT
7. Adams HP Jr, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. Stroke. 1994;25:1901-1914.
WEB OF SCIENCE
| PUBMED
8. Albers GW, Hart RG, Lutsep HL, et al. Supplement to the guidelines for the management of transient ischemic attacks. Stroke. 1999;30:2502-2511.
FREE FULL TEXT
9. Feinberg WM, Albers GW, Barnett HJ, et al. Guidelines for the management of transient ischemic attacks. Circulation. 1994;89:2950-2965.
FREE FULL TEXT
10. Health Care Financing Administration. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1997 rates—HCFA. Final rule. 61 Federal Register. 46166 (1996).
11. Oster G, Huse DM, Lacey MJ, Epstein AM. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. Stroke. 1994;25:1149-1156.
ABSTRACT
12. Hankey GJ, Warlow CP. Cost-effective investigation of patients with suspected transient ischaemic attacks [editorial]. J Neurol Neurosurg Psychiatry. 1992;55:171-176.
FREE FULL TEXT
13. Kernan WN, Horwitz RI, Brass LM, et al. A prognostic system for transient ischemia or minor stroke. Ann Intern Med. 1991;114:552-557.
FREE FULL TEXT
14. Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry. 1991;54:793-802.
FREE FULL TEXT
15. Muuronen A, Kaste M. Outcome of 314 patients with transient ischemic attacks. Stroke. 1982;13:24-31.
ABSTRACT
16. Sorensen PS, Marquardsen J, Pedersen H, et al. Long-term prognosis and quality of life after reversible cerebral ischemic attacks. Acta Neurol Scand. 1989;79:204-213.
WEB OF SCIENCE
| PUBMED
17. Calandre L, Bermejo F, Balseiro J. Long-term outcome of TIAs, RINDs and infarctions with minimum residuum. Acta Neurol Scand. 1990;82:104-108.
WEB OF SCIENCE
| PUBMED
18. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53-59.
ABSTRACT
19. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991;325:1261-1266.
ABSTRACT
20. EAFT Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.
WEB OF SCIENCE
| PUBMED
21. UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044-1054.
FREE FULL TEXT
22. Heyman A, Burch JG, Rosati R, et al. Use of a computerized information system in the management of patients with transient cerebral ischemia. Neurology. 1979;29:214-221.
FREE FULL TEXT
23. Heyman A, Wilkinson WE, Hurwitz BJ, et al. Risk of ischemic heart disease in patients with TIA. Neurology. 1984;34:626-630.
FREE FULL TEXT
24. Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry. 1992;55:640-652.
FREE FULL TEXT
25. Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973;48:194-198.
WEB OF SCIENCE
| PUBMED
26. Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990;21:848-853.
FREE FULL TEXT
27. Koudstaal PJ, Gerritsma JG, van Gijn J. Clinical disagreement on the diagnosis of transient ischemic attack. Stroke. 1989;20:300-301.
FREE FULL TEXT
28. Kraaijeveld CL, van Gijn J, Schouten HJ, Staal A. Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke. 1984;15:723-725.
FREE FULL TEXT
29. Kothari RU, Brott T, Broderick JP, Hamilton CA. Emergency physicians: accuracy in the diagnosis of stroke. Stroke. 1995;26:2238-2241.
FREE FULL TEXT
30. Johnston SC, Smith WS. Practice variability in management of transient ischemic attacks. Eur Neurol. 1999;42:105-108.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
31. Krieger N. Overcoming the absence of socioeconomic data in medical records. Am J Public Health. 1992;82:703-710.
FREE FULL TEXT
32. World Health Organization MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease). J Clin Epidemiol. 1988;41:105-114.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
33. Selby JV, Fireman BH, Lundstrom RJ, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med. 1996;335:1888-1896.
FREE FULL TEXT
34. Selby JV, Fireman BH, Swain BE. Effect of a copayment on use of the emergency department in a health maintenance organization. N Engl J Med. 1996;334:635-641.
FREE FULL TEXT
35. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
FREE FULL TEXT
36. Brown RD, Whisnant JP, Sicks JD, et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27:373-380.
WEB OF SCIENCE
| PUBMED
37. Dyken ML, Conneally M, Haerer AF, et al. Cooperative study of hospital frequency and character of transient ischemic attacks. JAMA. 1977;237:882-886.
FREE FULL TEXT
38. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA. 1997;277:488-494.
FREE FULL TEXT
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
December 13, 2000
JAMA. 2000;284(22):2947-2948.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Carotid Artery Imaging for Secondary Stroke Prevention: Both Imaging Modality and Rapid Access to Imaging Are Important
Wardlaw et al.
Stroke 2009;40:3511-3517.
ABSTRACT
| FULL TEXT
Diagnostic Usefulness of the ABCD2 Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events: The North Dublin TIA Study
Sheehan et al.
Stroke 2009;40:3449-3454.
ABSTRACT
| FULL TEXT
The impact of timing on outcomes of carotid artery stenting in recently symptomatic patients
Lin et al.
Journal of NeuroInterventional Surgery 2009;0:jnis.2009.000901v1-jnis.2009.000901.
ABSTRACT
| FULL TEXT
Early Diffusion Weighted MRI as a Negative Predictor for Disabling Stroke After ABCD2 Score Risk Categorization in Transient Ischemic Attack Patients
Asimos et al.
Stroke 2009;40:3252-3257.
ABSTRACT
| FULL TEXT
Can the ABCD2 Risk Score Predict Positive Diagnostic Testing for Emergency Department Patients Admitted for Transient Ischemic Attack?
Schrock et al.
Stroke 2009;40:3202-3205.
ABSTRACT
| FULL TEXT
Reflections on the Carotid Artery: 438 BC to 2009 AD: The Karolinska 2008 Award Lecture in Stroke Research
Barnett
Stroke 2009;40:3143-3148.
FULL TEXT
Vertebrobasilar Stenosis Predicts High Early Recurrent Stroke Risk in Posterior Circulation Stroke and TIA
Gulli et al.
Stroke 2009;40:2732-2737.
ABSTRACT
| FULL TEXT
High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis
Ois et al.
Stroke 2009;40:2727-2731.
ABSTRACT
| FULL TEXT
Validation and Refinement of the ABCD2 Score: A Population-Based Analysis
Fothergill et al.
Stroke 2009;40:2669-2673.
ABSTRACT
| FULL TEXT
Initial management of suspected transient cerebral ischaemia and stroke in primary care: implications of recent research
Lasserson
Postgrad. Med. J. 2009;85:422-427.
ABSTRACT
| FULL TEXT
Waiting times for carotid endarterectomy in UK: observational study
Halliday et al.
BMJ 2009;338:b1847-b1847.
ABSTRACT
| FULL TEXT
Population-based study of risk and predictors of stroke in the first few hours after a TIA
Chandratheva et al.
Neurology 2009;72:1941-1947.
ABSTRACT
| FULL TEXT
Elderly Women Have Lower Rates of Stroke, Cardiovascular Events, and Mortality After Hospitalization for Transient Ischemic Attack
Lichtman et al.
Stroke 2009;40:2116-2122.
ABSTRACT
| FULL TEXT
The California, ABCD, and Unified ABCD2 Risk Scores and the Presence of Acute Ischemic Lesions on Diffusion-Weighted Imaging in TIA Patients
Purroy et al.
Stroke 2009;40:2229-2232.
ABSTRACT
| FULL TEXT
Definition and Evaluation of Transient Ischemic Attack: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
Easton et al.
Stroke 2009;40:2276-2293.
ABSTRACT
| FULL TEXT
Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley et al.
Stroke 2009;40:e380-e389.
ABSTRACT
| FULL TEXT
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
Amarenco et al.
Stroke 2009;40:1405-1409.
ABSTRACT
| FULL TEXT
Personal Reflections From a Front-Row Seat at the Greatest Show on Earth (Life): Part II (Stroke Research Commentary)
Barnett
Stroke 2009;40:e53-e65.
FULL TEXT
Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT
Carotid Atherosclerotic Plaques Stabilize After Stroke: Insights Into the Natural Process of Atherosclerotic Plaque Stabilization
Peeters et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:128-133.
ABSTRACT
| FULL TEXT
Clinical- and Imaging-Based Prediction of Stroke Risk After Transient Ischemic Attack: The CIP Model
Ay et al.
Stroke 2009;40:181-186.
ABSTRACT
| FULL TEXT
DWI Lesions and TIA Etiology Improve the Prediction of Stroke After TIA
Calvet et al.
Stroke 2009;40:187-192.
ABSTRACT
| FULL TEXT
Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography
Jaff et al.
Vasc Med 2008;13:281-292.
ABSTRACT
Higher ABCD2 Score Predicts Patients Most Likely to Have True Transient Ischemic Attack
Josephson et al.
Stroke 2008;39:3096-3098.
ABSTRACT
| FULL TEXT
Influence of general practice opening hours on delay in seeking medical attention after transient ischaemic attack (TIA) and minor stroke: prospective population based study
Lasserson et al.
BMJ 2008;337:a1569-a1569.
ABSTRACT
| FULL TEXT
Recurrent Events in Transient Ischemic Attack and Minor Stroke: What Events Are Happening and to Which Patients?
Coutts et al.
Stroke 2008;39:2461-2466.
ABSTRACT
| FULL TEXT
EXPRESS Transient Ischemic Attack Study: Speed the Process!
Amarenco and Benavente
Stroke 2008;39:2400-2401.
FULL TEXT
Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis
Ovbiagele et al.
Arch Neurol 2008;65:733-737.
ABSTRACT
| FULL TEXT
Factors Associated With a High Risk of Recurrence in Patients With Transient Ischemic Attack or Minor Stroke
Ois et al.
Stroke 2008;39:1717-1721.
ABSTRACT
| FULL TEXT
Outpatient Practice Patterns After Stroke Hospitalization Among Neurologists
Ovbiagele et al.
Stroke 2008;39:1850-1854.
ABSTRACT
| FULL TEXT
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke: A Critical Review
O'Donnell et al.
Stroke 2008;39:1638-1646.
ABSTRACT
| FULL TEXT
Factors Associated With the Decision to Hospitalize Patients After Transient Ischemic Attack Before Publication of Prediction Rules
Josephson et al.
Stroke 2008;39:411-413.
ABSTRACT
| FULL TEXT
Rapid Identification of High-Risk Transient Ischemic Attacks: Prospective Validation of the ABCD Score
Sciolla et al.
Stroke 2008;39:297-302.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Writing Group Members et al.
Circulation 2008;117:e25-e146.
FULL TEXT
Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects
Sacchetti et al.
J Psychopharmacol 2008;22:39-46.
ABSTRACT
Prognosis in patients with transient ischaemic attack (TIA) and minor stroke attending TIA services in the North West of England: The NORTHSTAR Study
Selvarajah et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:38-43.
ABSTRACT
| FULL TEXT
Incidence and Prognosis of Transient Neurological Attacks
Bos et al.
JAMA 2007;298:2877-2885.
ABSTRACT
| FULL TEXT
Transient Neurological Attack: A Useful Concept?
Johnston
JAMA 2007;298:2912-2913.
FULL TEXT
Early Risk of Stroke After Transient Ischemic Attack: A Systematic Review and Meta-analysis
Wu et al.
Arch Intern Med 2007;167:2417-2422.
ABSTRACT
| FULL TEXT
Patterns and Predictors of Early Risk of Recurrence After Transient Ischemic Attack With Respect to Etiologic Subtypes
Purroy et al.
Stroke 2007;38:3225-3229.
ABSTRACT
| FULL TEXT
Antiplatelet medication management in patients hospitalized with ischemic stroke
Nickman et al.
Am J Health Syst Pharm 2007;64:2250-2256.
ABSTRACT
| FULL TEXT
Can risk stratification of transient ischaemic attacks improve patient care in the emergency department?
Byrne et al.
Emerg. Med. J. 2007;24:637-640.
ABSTRACT
| FULL TEXT
Transient ischaemic attacks: time to wake up
Rothwell
Heart 2007;93:893-894.
ABSTRACT
| FULL TEXT
Transient Ischemic Attack With Abnormal Diffusion-Weighted Imaging Results: What's in a Name?
Caplan
Arch Neurol 2007;64:1080-1082.
FULL TEXT
Impact of Abnormal Diffusion-Weighted Imaging Results on Short-term Outcome Following Transient Ischemic Attack
Prabhakaran et al.
Arch Neurol 2007;64:1105-1109.
ABSTRACT
| FULL TEXT
Diffusion-Weighted Imaging-Negative Patients With Transient Ischemic Attack Are at Risk of Recurrent Transient Events
Boulanger et al.
Stroke 2007;38:2367-2369.
ABSTRACT
| FULL TEXT
Carotid endarterectomy in patients with acute neurological symptoms: a case-control study
Dorigo et al.
ICVTS 2007;6:369-373.
ABSTRACT
| FULL TEXT
Systematic Review of Associations Between the Presence of Acute Ischemic Lesions on Diffusion-Weighted Imaging and Clinical Predictors of Early Stroke Risk After Transient Ischemic Attack
Redgrave et al.
Stroke 2007;38:1482-1488.
ABSTRACT
| FULL TEXT
Attitudes and Current Practice of Primary Care Physicians in Acute Stroke Management
Roebers et al.
Stroke 2007;38:1298-1303.
ABSTRACT
| FULL TEXT
Secondary Prevention of Stroke and Transient Ischemic Attack: Is More Platelet Inhibition the Answer?
Liao
Circulation 2007;115:1615-1621.
ABSTRACT
| FULL TEXT
Defining Cause of Death in Stroke Patients: The Brain Attack Surveillance in Corpus Christi Project
Brown et al.
Am J Epidemiol 2007;165:591-596.
ABSTRACT
| FULL TEXT
Absence of Usefulness of ABCD Score in the Early Risk of Stroke of Transient Ischemic Attack Patients
Purroy et al.
Stroke 2007;38:855-856.
FULL TEXT
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
Bates et al.
Vasc Med 2007;12:35-83.
Can the ABCD Score be dichotomised to identify high-risk patients with transient ischaemic attack in the emergency department?
Bray et al.
Emerg. Med. J. 2007;24:92-95.
ABSTRACT
| FULL TEXT
Primary Prevention and Health Services Delivery
Goldstein and Rothwell
Stroke 2007;38:222-224.
FULL TEXT
Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study.
Cruz-Flores et al.
Neurology 2007;68:241-242.
FULL TEXT
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
American Society of Interventional & Therapeutic N et al.
J Am Coll Cardiol 2007;49:126-170.
FULL TEXT
Validation of the ABCD Score in Identifying Individuals at High Early Risk of Stroke After a Transient Ischemic Attack: A Hospital-Based Case Series Study
Tsivgoulis et al.
Stroke 2006;37:2892-2897.
ABSTRACT
| FULL TEXT
High Prevalence of Stroke Symptoms Among Persons Without a Diagnosis of Stroke or Transient Ischemic Attack in a General Population: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.
Howard et al.
Arch Intern Med 2006;166:1952-1958.
ABSTRACT
| FULL TEXT
Update on clopidogrel and dual anti-platelet therapy: neurology
Diener
Eur Heart J Suppl 2006;8:G15-G19.
ABSTRACT
| FULL TEXT
Is the ABCD Score Useful for Risk Stratification of Patients With Acute Transient Ischemic Attack?
Cucchiara et al.
Stroke 2006;37:1710-1714.
ABSTRACT
| FULL TEXT
Is the ABCD Score Truly Useful?
Hill and Weir
Stroke 2006;37:1636-1636.
FULL TEXT
Patient Behavior Immediately After Transient Ischemic Attack According to Clinical Characteristics, Perception of the Event, and Predicted Risk of Stroke
Giles et al.
Stroke 2006;37:1254-1260.
ABSTRACT
| FULL TEXT
Medical academia is failing patients and clinicians.
Rothwell
BMJ 2006;332:863-864.
FULL TEXT
Patients With Transient Ischemic Attack or Minor Stroke Should Be Admitted to Hospital: For
Donnan et al.
Stroke 2006;37:1137-1138.
FULL TEXT
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Circulation 2006;113:e409-e449.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom et al.
Circulation 2006;113:e85-e151.
FULL TEXT
Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions
Reilly and Evans
ANN INTERN MED 2006;144:201-209.
ABSTRACT
| FULL TEXT
A simple risk score predicted 7 day stroke risk after transient ischaemic attack
Hart
Evid. Based Med. 2006;11:27-27.
FULL TEXT
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Stroke 2006;37:577-617.
ABSTRACT
| FULL TEXT
Transient Ischemic Attacks: Stratifying Risk
Rothwell and Johnston
Stroke 2006;37:320-322.
FULL TEXT
Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis
Kasner et al.
Circulation 2006;113:555-563.
ABSTRACT
| FULL TEXT
Results of the Management of Atherothrombosis With Clopidogrel in High-Risk Patients Trial: Implications for the Neurologist
Fisher
Arch Neurol 2006;63:20-24.
ABSTRACT
| FULL TEXT
Transient Ischemic Attacks in Rural and Urban Northern Portugal: Incidence and Short-Term Prognosis
Correia et al.
Stroke 2006;37:50-55.
ABSTRACT
| FULL TEXT
Is hospitalization after TIA cost-effective on the basis of treatment with tPA?
Nguyen-Huynh and Johnston
Neurology 2005;65:1799-1801.
ABSTRACT
| FULL TEXT
Letter Regarding Article by Markus et al, "Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Cardiac Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reducton of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial" * Response
Imray et al.
Circulation 2005;112:e325-e326.
FULL TEXT
Long-Term Therapy to Prevent Stroke
Kirshner et al.
J Am Board Fam Med 2005;18:528-540.
ABSTRACT
| FULL TEXT
Perfusion MRI Abnormalities in Speech or Motor Transient Ischemic Attack Patients
Krol et al.
Stroke 2005;36:2487-2489.
ABSTRACT
| FULL TEXT
Imaging of acute stroke and transient ischaemic attack
Muir and Santosh
J. Neurol. Neurosurg. Psychiatry 2005;76:iii19-iii28.
FULL TEXT
Antihypertensive Medications Prescribed at Discharge After an Acute Ischemic Cerebrovascular Event
Ovbiagele et al.
Stroke 2005;36:1944-1947.
ABSTRACT
| FULL TEXT
Antiplatelet Agents in Secondary Prevention of Stroke: A Perspective
Norris
Stroke 2005;36:2034-2036.
ABSTRACT
| FULL TEXT
Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke
Fairhead et al.
Neurology 2005;65:371-375.
ABSTRACT
| FULL TEXT
A study of the workload and effectiveness of a comprehensive acute stroke service
Weir and Buchan
J. Neurol. Neurosurg. Psychiatry 2005;76:863-865.
ABSTRACT
| FULL TEXT
Is This Patient Having a Stroke?
Goldstein and Simel
JAMA 2005;293:2391-2402.
ABSTRACT
| FULL TEXT
Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial
Markus et al.
Circulation 2005;111:2233-2240.
ABSTRACT
| FULL TEXT
Asymptomatic Embolization Detected by Doppler Ultrasound Predicts Stroke Risk in Symptomatic Carotid Artery Stenosis
Markus and MacKinnon
Stroke 2005;36:971-975.
ABSTRACT
| FULL TEXT
Editorial Comment-- Transient Ischemic Attacks Are Emergencies
Johnston
Stroke 2005;36:724-724.
FULL TEXT
Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study
Kleindorfer et al.
Stroke 2005;36:720-723.
ABSTRACT
| FULL TEXT
Timing of TIAs preceding stroke: Time window for prevention is very short
Rothwell and Warlow
Neurology 2005;64:817-820.
ABSTRACT
| FULL TEXT
DWI Abnormalities and Clinical Characteristics in TIA Patients
Graybeal and Unwin
PERSPECT VASC SURG ENDOVASC THER 2005;17:64-1-65.
ABSTRACT
Use of Magnetic Resonance Imaging in Predicting Further Vascular Events Among Patients With Transient Ischemic Attacks * Response:
Boulanger et al.
Stroke 2005;36:526-528.
FULL TEXT
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study
Gill et al.
BMJ 2005;330:445.
ABSTRACT
| FULL TEXT
Ischaemic stroke in young adults: predictors of outcome and recurrence
Nedeltchev et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:191-195.
ABSTRACT
| FULL TEXT
Is the rapid assessment stroke clinic rapid enough in assessing transient ischaemic attack and minor stroke?
Widjaja et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:145-146.
FULL TEXT
Early Recurrence of Cerebrovascular Events After Transient Ischaemic Attack
Whitehead et al.
Stroke 2005;36:1-1.
FULL TEXT
Yield and Accuracy of Urgent Combined Carotid/Transcranial Ultrasound Testing in Acute Cerebral Ischemia
Chernyshev et al.
Stroke 2005;36:32-37.
ABSTRACT
| FULL TEXT
Emergency department evaluation of ischemic stroke and TIA: The BASIC Project
Brown et al.
Neurology 2004;63:2250-2254.
ABSTRACT
| FULL TEXT
Early and late recurrence of ischemic lesion on MRI: Evidence for a prolonged stroke-prone state?
Kang et al.
Neurology 2004;63:2261-2265.
ABSTRACT
| FULL TEXT
|
